MSR1

Chr 8

macrophage scavenger receptor 1

Also known as: CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII, SRA, phSR1

This gene encodes class A macrophage scavenger receptors that mediate endocytosis of modified low-density lipoproteins and other macromolecules in macrophages. Mutations are associated with Barrett esophagus and esophageal adenocarcinoma with autosomal dominant inheritance. The gene shows low constraint to loss-of-function variants, suggesting haploinsufficiency may not be the primary disease mechanism.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Barrett esophagus/esophageal adenocarcinomaMIM #614266
UniProtProstate cancer
0
Active trials
44
Pubs (1 yr)
92
P/LP submissions
5%
P/LP missense
1.70
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMSR1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
92 unique Pathogenic / Likely Pathogenic· 89 VUS of 236 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.70LOEUF
pLI 0.000
Z-score -1.05
OE 1.24 (0.921.70)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-2.07Z-score
OE missense 1.37 (1.251.50)
341 obs / 249.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.24 (0.921.70)
00.351.4
Missense OE1.37 (1.251.50)
00.61.4
Synonymous OE1.19
01.21.6
LoF obs/exp: 27 / 21.7Missense obs/exp: 341 / 249.1Syn Z: -1.43
DN
0.7132th %ile
GOF
0.6735th %ile
LOF
0.3941th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

236 submitted variants in ClinVar

Classification Summary

Pathogenic81
Likely Pathogenic11
VUS89
Likely Benign17
Benign15
Conflicting2
81
Pathogenic
11
Likely Pathogenic
89
VUS
17
Likely Benign
15
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
1
79
0
81
Likely Pathogenic
1
4
6
0
11
VUS
2
73
14
0
89
Likely Benign
1
5
9
2
17
Benign
0
4
5
6
15
Conflicting
2
Total5871138215

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MSR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →